• Info
  • Significant Ownership

Significant Ownership of BML Investment Partners, L.P.

Signature - Title
Braden M Leonard - BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Location
Zionsville, IN
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BML Investment Partners, L.P..

Follow Filing Activity

Follow BML Investment Partners, L.P. and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of BML Investment Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 12% $37,620,000 14,250,000 0% BML Investment Partners, L.P. 31 Dec 2025
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 10% $9,739,269 +$1,005,184 1,902,201 +12% BML Investment Partners, L.P. 12 Feb 2026
ACHL Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share 10% $6,066,773 4,100,002 BML Investment Partners, L.P. 31 Dec 2024
AVIR Atea Pharmaceuticals, Inc. Common Stock 9.9% $27,881,700 +$2,119,466 7,810,000 +8.2% Leonard Braden Michael 31 Dec 2025
PMVP PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share 9.9% $6,615,000 +$2,527,616 5,292,000 +62% BML Investment Partners, L.P. 31 Dec 2025
KZR Kezar Life Sciences, Inc. Common Stock, $0.001 par value 9.8% 720,787 +96% BML Investment Partners, L.P. 31 Dec 2025
EPIX ESSA Pharma Inc. Common Shares 9.5% $7,598,783 +$68,981 4,221,546 +0.92% BML Investment Partners, L.P. 24 Apr 2025
TIL Instil Bio, Inc. Common Stock, $0.000001 par value per share 9.5% +$2,261,600 645,600 +47% BML Investment Partners, L.P. 31 Dec 2025
TLYS Tilly's, Inc. Class A Common Stock, $0.001 par value per share 9.4% $3,130,536 2,189,186 Leonard Braden Michael 12 Mar 2026
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.5% $4,335,508 +$470,890 4,090,102 +12% Leonard Braden Michael 16 Jun 2025
ORMP ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share 8.3% $11,276,231 +$2,207,630 3,287,531 +24% Leonard Braden Michael 31 Dec 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 8.2% $19,179,460 3,724,167 BML Investment Partners, L.P. 11 Feb 2025
LVTX LAVA Therapeutics N.V. Common shares, par value $0.14 per share 7.4% $2,702,192 1,958,110 BML Investment Partners, L.P. 26 Feb 2025
WHWK Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 5% $3,749,900 -$331,178 2,435,000 0% Leonard Braden Michael 05 Mar 2025
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 1.9% 220,832 Leonard Braden Michael 25 Jul 2025
ANTX AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share 1.4% $551,387 -$3,599,088 427,432 -87% BML Investment Partners, L.P. 17 Jun 2025
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BML Investment Partners, L.P. 31 Dec 2024
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 0% $0 0 BML Investment Partners, L.P. 31 Dec 2024
ASTC Astrotech Corporation Common Stock, $0.001 par value per share 0% $0 0 BML Investment Partners, L.P. 03 Oct 2025
ATHA Athira Pharma Inc. Common Stock, $0.0001 par value 0% $0 -$5,608,138 0 -100% BML Investment Partners, L.P. 18 Dec 2025
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 0% $0 -$2,162,562 0 -100% BML Investment Partners, L.P. 23 Jul 2025
ADVM Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share 0% -$9,738,956 0 -100% BML Investment Partners, L.P. 09 Dec 2025

Schedules 13D/G Reported by BML Investment Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored